Influence of Quaternary Ammonium Salt Functionalized Chitosan Additive as Sustainable Filler for High-Density Polyethylene Composites.

In this study, an antimicrobial packaging material was successfully developed with blends of high-density polyethylene (HDPE) and chitosan (CS) made by melt processing. In the different HDPE/CS composites, the CS content effect (up to 40%), and the addition of quaternary ammonium salt functionalized chitosan (CS-CTAB) as an additive were evaluated by X-ray diffraction (XRD), differential scanning calorimetry (DSC), thermogravimetric analyses (TG), tensile strength, scanning electron microscopy (SEM) and antimicrobial activity. When analyzing the effect of the additive in the different HDPE/CS composites, it was observed that the compositions with 10 and 20 %wt of chitosan showed better elongation values (~13% and 10%) as well as a higher decomposition temperature at 20% mass loss (T20) varying from (321-332 °C and 302-312 °C), respectively, in relation to the other compositions, regardless of the type of additive used, it acted as an antimicrobial agent, promoting inhibition of microbial growth against the strains gram-positive and gram-negative used in this work, making the different HDPE/CS composites suitable candidates for use in food packaging.

Contribution of genetic polymorphisms of interleukins IL1B-511 C/T, IL1RN VNTR, IL6-174 G/C, and IL8-251 A/T in gastric lesions: gender and Helicobacter pylori genes matter.

Stomach pathologies develop in a complex interaction between the host's genetic background and H. pylori virulent genes. Thus, our study aimed to compare active chronic gastritis (ACG), and intestinal metaplasia (IM) with inactive chronic gastritis (ICG), according to interleukin polymorphisms of IL6-174 G/C, IL8-251 A/T, IL1β-511 C/T, and IL1RN VNTR taking into account patient gender and H.

Progress in the Development of Chitosan Based Insulin Delivery Systems: A Systematic Literature Review.

Diabetes mellitus is a chronic disease that is considered a worldwide epidemic, and its control is a constant challenge for health systems. Since insulin had its first successful use, scientists have researched to improve the desired effects and reduce side-effects. Over the years, the challenge has been to increase adherence to treatment and improve the quality of life for diabetics by developing an insulin delivery system.